Urine vascular biomarkers in Sturge-Weber syndrome.

about

Current Therapeutic Options in Sturge-Weber Syndrome Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research.

P2860

Q26771926-63D93368-E544-4CFD-A12F-E9DAE097051C Q33902151-C9900207-ECC8-484C-9D44-84EB9F81FF96

P2860

Urine vascular biomarkers in Sturge-Weber syndrome.

Item

http://www.wikidata.org/entity/Q46610900

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Urine vascular biomarkers in Sturge-Weber syndrome.

@en

Urine vascular biomarkers in Sturge-Weber syndrome.

@nl

type

Item

label

Urine vascular biomarkers in Sturge-Weber syndrome.

@en

Urine vascular biomarkers in Sturge-Weber syndrome.

@nl

prefLabel

Urine vascular biomarkers in Sturge-Weber syndrome.

@en

Urine vascular biomarkers in Sturge-Weber syndrome.

@nl

P1476

Urine vascular biomarkers in Sturge-Weber syndrome.

@en

P2093

Adam S Curatolo

http://www.w3.org/2001/XMLSchema#string

Aditya K Sreenivasan

http://www.w3.org/2001/XMLSchema#string

Anne M Comi

http://www.w3.org/2001/XMLSchema#string

Catherine D Bachur

http://www.w3.org/2001/XMLSchema#string

Kira E Lanier

http://www.w3.org/2001/XMLSchema#string

Marsha A Moses

http://www.w3.org/2001/XMLSchema#string

Susan M Connors

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.

Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus.

Sturge-Weber syndrome: a review.

Age-dependent loss of MMP-3 in Hutchinson-Gilford progeria syndrome

Effects of metalloproteinase inhibition in a murine model of renal ischemia-reperfusion injury

Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction

Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome.

Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin.

Calcium in ischemic cell death.

Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy.

P304

122-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1358863X13486312

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23720035

http://www.w3.org/2001/XMLSchema#string

Urine vascular biomarkers in Sturge-Weber syndrome.

about

P2860

P2860

Urine vascular biomarkers in Sturge-Weber syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698